Journal article icon

Journal article : Review

Neuromodulation in 2035: The Neurology future forecasting series

Abstract:

Neuromodulation devices are approved in the United States for the treatment of movement disorders, epilepsy, pain, and depression, and are used off-label for other neurologic indications. By 2035, advances in our understanding of neuroanatomical networks and in the mechanism of action of stimulation, coupled with developments in material science, miniaturization, energy storage, and delivery, will expand the use of neuromodulation devices. Neuromodulation approaches are flexible and modifiabl...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1212/wnl.0000000000013061

Authors


More by this author
Institution:
University of Oxford
Division:
MPLS
Department:
Engineering Science
Role:
Author
Publisher:
American Academy of Neurology
Journal:
Neurology More from this journal
Volume:
98
Issue:
2
Pages:
65-72
Publication date:
2022-01-10
Acceptance date:
2021-11-08
DOI:
EISSN:
1526-632X
ISSN:
0028-3878
Pmid:
35263267
Language:
English
Keywords:
Subtype:
Review
Pubs id:
1310895
Local pid:
pubs:1310895
Deposit date:
2023-01-24

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP